Medicamen Biotech standalone net profit rises 18100.00% in the March 2016 quarter

Sales decline 3.18% to Rs 17.98 crore

Net profit of Medicamen Biotech rose 18100.00% to Rs 1.82 crore in the quarter ended March 2016 as against Rs 0.01 crore during the previous quarter ended March 2015. Sales declined 3.18% to Rs 17.98 crore in the quarter ended March 2016 as against Rs 18.57 crore during the previous quarter ended March 2015.

For the full year,net profit rose 9.09% to Rs 0.48 crore in the year ended March 2016 as against Rs 0.44 crore during the previous year ended March 2015. Sales declined 13.51% to Rs 67.28 crore in the year ended March 2016 as against Rs 77.79 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales17.9818.57 -3 67.2877.79 -14 OPM %19.135.28 -7.455.05 - PBDT2.640.30 780 2.612.22 18 PBT2.16-0.22 LP 0.710.12 492 NP1.820.01 18100 0.480.44 9

Powered by Capital Market - Live News